Mouse mammary tumor virus-based vector transduces non-dividing cells, enters the nucleus via a TNPO3-independent pathway and integrates in a less biased fashion than other retroviruses

Retrovirology

Volumn 11, Issue 1, 2014, Pages

  Konstantoulas, Constantine J ^a   Indik, Stanislav ^a  

^a UNIVERSITY OF VETERINARY MEDICINE   (Austria)

Author keywords

Betaretrovirus; Integrase; MMTV; Non dividing cells; Random integration; TNPO3

Indexed keywords

CELL PROTEIN; TNOP3 PROTEIN; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS RNA; VIRUS VECTOR; ENHANCED GREEN FLUORESCENT PROTEIN; GREEN FLUORESCENT PROTEIN; KARYOPHERIN BETA; LENTIVIRUS VECTOR; MOUSE MAMMARY TUMOR VIRUS VECTOR; PROTEIN; RETROVIRUS VECTOR; TRANSPORTIN 3;

ANIMAL CELL; ARTICLE; G2 PHASE CELL CYCLE CHECKPOINT; GENETIC TRANSFECTION; GENOME ANALYSIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; LENTIVIRINAE; MOLECULAR DYNAMICS; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; MULTICENTER STUDY; NONHUMAN; NUCLEAR IMPORT; NUCLEOTIDE SEQUENCE; PROTEIN DEPLETION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA SEQUENCE; RNA SPLICING; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; SPECIES DIFFERENCE; TRANSCRIPTION REGULATION; VIROGENESIS; VIRUS DNA CELL DNA INTERACTION; VIRUS GENOME; VIRUS IDENTIFICATION; VIRUS INFECTIVITY; VIRUS TITRATION; ANIMAL; CELL LINE; CELL NUCLEUS; GENE EXPRESSION; GENE VECTOR; GENETICS; HEK293 CELL LINE; HELA CELL LINE; HUMAN IMMUNODEFICIENCY VIRUS 1; PHYSIOLOGY; PROCEDURES; RETROVIRUS; RNA PROCESSING; TRANSCRIPTION INITIATION SITE; TUMOR CELL LINE; CHROMOSOME; CONTROLLED STUDY; GENE SILENCING; GENETIC TRANSDUCTION;

ANIMALS; BETA KARYOPHERINS; CELL LINE; CELL LINE, TUMOR; CELL NUCLEUS; G2 PHASE CELL CYCLE CHECKPOINTS; GENE EXPRESSION; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HEK293 CELLS; HELA CELLS; HIV-1; HUMANS; MAMMARY TUMOR VIRUS, MOUSE; MICE; RETROVIRIDAE; RNA PROCESSING, POST-TRANSCRIPTIONAL; TRANSCRIPTION INITIATION SITE; TRANSFECTION; VIRUS INTEGRATION;

BETARETROVIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MOUSE MAMMARY TUMOR VIRUS;

EID: 84901945841     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-11-34     Document Type: Article

References (53)

1. Bittner JJ. Some possible effects of nursing on the mammary gland tumor incidence in mice. Science 1936, 84:162.
2. Dzuris JL, Golovkina TV, Ross SR. Both T and B cells shed infectious mouse mammary tumor virus. J Virol 1997, 71:6044-6048. 191862, 9223496.
3. Vacheron S, Luther SA, Acha-Orbea H. Preferential infection of immature dendritic cells and B cells by mouse mammary tumor virus. J Immunol 2002, 168:3470-3476. 10.4049/jimmunol.168.7.3470, 11907107.
4. Indik S, Gunzburg WH, Salmons B, Rouault F. Mouse mammary tumor virus infects human cells. Cancer Res 2005, 65:6651-6659. 10.1158/0008-5472.CAN-04-2609, 16061645.
5. Gunzburg WH, Salmons B. Mouse mammary tumor virus mediated transfer and expression of neomycin resistance to infected cultured cells. Virology 1986, 155:236-248. 10.1016/0042-6822(86)90183-2, 3022473.
6. Shackleford GM, Varmus HE. Construction of a clonable, infectious, and tumorigenic mouse mammary tumor virus provirus and a derivative genetic vector. Proc Natl Acad Sci U S A 1988, 85:9655-9659. 10.1073/pnas.85.24.9655, 282828, 2849114.
7. Indik S, Gunzburg WH, Salmons B, Rouault F. A novel, mouse mammary tumor virus encoded protein with Rev-like properties. Virology 2005, 337:1-6. 10.1016/j.virol.2005.03.040, 15914215.
8. Mertz JA, Simper MS, Lozano MM, Payne SM, Dudley JP. Mouse mammary tumor virus encodes a self-regulatory RNA export protein and is a complex retrovirus. J Virol 2005, 79:14737-14747. 10.1128/JVI.79.23.14737-14747.2005, 1287593, 16282474.
9. Mullner M, Salmons B, Gunzburg WH, Indik S. Identification of the Rem-responsive element of mouse mammary tumor virus. Nucleic Acids Res 2008, 36:6284-6294. 10.1093/nar/gkn608, 2577329, 18835854.
10. Mertz JA, Chadee AB, Byun H, Russell R, Dudley JP. Mapping of the functional boundaries and secondary structure of the mouse mammary tumor virus Rem-responsive element. J Biol Chem 2009, 284:25642-25652. 10.1074/jbc.M109.012476, 2757966, 19632991.
11. Faschinger A, Rouault F, Sollner J, Lukas A, Salmons B, Gunzburg WH, Indik S. Mouse mammary tumor virus integration site selection in human and mouse genomes. J Virol 2008, 82:1360-1367. 10.1128/JVI.02098-07, 2224419, 18032509.
12. Wu X, Li Y, Crise B, Burgess SM. Transcription start regions in the human genome are favored targets for MLV integration. Science 2003, 300:1749-1751. 10.1126/science.1083413, 12805549.
13. Schroder AR, Shinn P, Chen H, Berry C, Ecker JR, Bushman F. HIV-1 integration in the human genome favors active genes and local hotspots. Cell 2002, 110:521-529. 10.1016/S0092-8674(02)00864-4, 12202041.
14. Dull T, Zufferey R, Kelly M, Mandel RJ, Nguyen M, Trono D, Naldini L. A third-generation lentivirus vector with a conditional packaging system. J Virol 1998, 72:8463-8471. 110254, 9765382.
15. Salmons B, Moritz-Legrand S, Garcha I, Gunzburg WH. Construction and characterization of a packaging cell line for MMTV-based conditional retroviral vectors. Biochem Biophys Res Commun 1989, 159:1191-1198. 10.1016/0006-291X(89)92236-5, 2539144.
16. Naldini L, Blomer U, Gage FH, Trono D, Verma IM. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc Natl Acad Sci U S A 1996, 93:11382-11388. 10.1073/pnas.93.21.11382, 38066, 8876144.
17. Burns JC, Friedmann T, Driever W, Burrascano M, Yee JK. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc Natl Acad Sci U S A 1993, 90:8033-8037. 10.1073/pnas.90.17.8033, 47282, 8396259.
18. Salmons B, Groner B, Calberg-Bacq CM, Ponta H. Production of mouse mammary tumor virus upon transfection of a recombinant proviral DNA into cultured cells. Virology 1985, 144:101-114. 10.1016/0042-6822(85)90309-5, 2998037.
19. Huang J, Liang TJ. A novel hepatitis B virus (HBV) genetic element with Rev response element-like properties that is essential for expression of HBV gene products. Mol Cell Biol 1993, 13:7476-7486. 364819, 8246965.
20. Zufferey R, Donello JE, Trono D, Hope TJ. Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors. J Virol 1999, 73:2886-2892. 104046, 10074136.
21. Mertz JA, Lozano MM, Dudley JP. Rev and Rex proteins of human complex retroviruses function with the MMTV Rem-responsive element. Retrovirology 2009, 6:10. 10.1186/1742-4690-6-10, 2661877, 19192308.
22. Yee JK, Miyanohara A, LaPorte P, Bouic K, Burns JC, Friedmann T. A general method for the generation of high-titer, pantropic retroviral vectors: highly efficient infection of primary hepatocytes. Proc Natl Acad Sci U S A 1994, 91:9564-9568. 10.1073/pnas.91.20.9564, 44853, 7937806.
23. Stripecke R, Koya RC, Ta HQ, Kasahara N, Levine AM. The use of lentiviral vectors in gene therapy of leukemia: combinatorial gene delivery of immunomodulators into leukemia cells by state-of-the-art vectors. Blood Cells Mol Dis 2003, 31:28-37. 10.1016/S1079-9796(03)00062-7, 12850480.
24. Hlavaty J, Portsmouth D, Stracke A, Salmons B, Gunzburg WH, Renner M. Effects of sequences of prokaryotic origin on titer and transgene expression in retroviral vectors. Virology 2004, 330:351-360. 10.1016/j.virol.2004.09.012, 15527860.
25. Venkataraman K, Brown KM, Gilmartin GM. Analysis of a noncanonical poly(A) site reveals a tripartite mechanism for vertebrate poly(A) site recognition. Genes Dev 2005, 19:1315-1327. 10.1101/gad.1298605, 1142555, 15937220.
26. Hu J, Lutz CS, Wilusz J, Tian B. Bioinformatic identification of candidate cis-regulatory elements involved in human mRNA polyadenylation. RNA 2005, 11:1485-1493. 10.1261/rna.2107305, 1370832, 16131587.
27. Weinberg JB, Matthews TJ, Cullen BR, Malim MH. Productive human immunodeficiency virus type 1 (HIV-1) infection of nonproliferating human monocytes. J Exp Med 1991, 174:1477-1482. 10.1084/jem.174.6.1477, 2119042, 1720811.
28. Rubin H, Temin HM. A radiological study of cell-virus interaction in the Rous sarcoma. Virology 1959, 7:75-91. 10.1016/0042-6822(59)90178-3, 13636057.
29. Lewis P, Hensel M, Emerman M. Human immunodeficiency virus infection of cells arrested in the cell cycle. EMBO J 1992, 11:3053-3058. 556788, 1322294.
30. Katz RA, Greger JG, Darby K, Boimel P, Rall GF, Skalka AM. Transduction of interphase cells by avian sarcoma virus. J Virol 2002, 76:5422-5434. 10.1128/JVI.76.11.5422-5434.2002, 137034, 11991971.
31. Hatziioannou T, Goff SP. Infection of nondividing cells by Rous sarcoma virus. J Virol 2001, 75:9526-9531. 10.1128/JVI.75.19.9526-9531.2001, 114520, 11533215.
32. Brown PO. Integration. Retroviruses 1997, 161-203. Cold Spring Harbour, N.Y: Cold Spring Harbour Laboratory Press, Coffin JM, Hughes SH, Varmus HE.
33. Bieniasz PD, Weiss RA, McClure MO. Cell cycle dependence of foamy retrovirus infection. J Virol 1995, 69:7295-7299. 189657, 7474157.
34. Karapetian O, Shakhov AN, Kraehenbuhl JP, Acha-Orbea H. Retroviral infection of neonatal Peyer's patch lymphocytes: the mouse mammary tumor virus model. J Exp Med 1994, 180:1511-1516. 10.1084/jem.180.4.1511, 2191709, 7931081.
35. Lee K, Ambrose Z, Martin TD, Oztop I, Mulky A, Julias JG, Vandegraaff N, Baumann JG, Wang R, Yuen W, Takemura T, Shelton K, Taniuchi I, Li Y, Sodroski J, Littman DR, Coffin JM, Hughes SH, Unutmaz D, Engelman A, KewalRamani VN. Flexible use of nuclear import pathways by HIV-1. Cell Host Microbe 2010, 7:221-233. 10.1016/j.chom.2010.02.007, 2841689, 20227665.
36. Schaller T, Ocwieja KE, Rasaiyaah J, Price AJ, Brady TL, Roth SL, Hue S, Fletcher AJ, Lee K, KewalRamani VN, Noursadeghi M, Jenner RG, James LC, Bushman FD, Towers GJ. HIV-1 capsid-cyclophilin interactions determine nuclear import pathway, integration targeting and replication efficiency. PLoS Pathog 2011, 7:e1002439. 10.1371/journal.ppat.1002439, 3234246, 22174692.
37. Konig R, Zhou Y, Elleder D, Diamond TL, Bonamy GM, Irelan JT, Chiang CY, Tu BP, De Jesus PD, Lilley CE, Seidel S, Opaluch AM, Caldwell JS, Weitzman MD, Kuhen KL, Bandyopadhyay S, Ideker T, Orth AP, Miraglia LJ, Bushman FD, Young JA, Chanda SK. Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. Cell 2008, 135:49-60. 10.1016/j.cell.2008.07.032, 2628946, 18854154.
38. Krishnan L, Matreyek KA, Oztop I, Lee K, Tipper CH, Li X, Dar MJ, Kewalramani VN, Engelman A. The requirement for cellular transportin 3 (TNPO3 or TRN-SR2) during infection maps to human immunodeficiency virus type 1 capsid and not integrase. J Virol 2010, 84:397-406. 10.1128/JVI.01899-09, 2798409, 19846519.
39. Mitchell RS, Beitzel BF, Schroder AR, Shinn P, Chen H, Berry CC, Ecker JR, Bushman FD. Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences. PLoS Biol 2004, 2:E234. 10.1371/journal.pbio.0020234, 509299, 15314653.
40. Derse D, Crise B, Li Y, Princler G, Lum N, Stewart C, McGrath CF, Hughes SH, Munroe DJ, Wu X. Human T-cell leukemia virus type 1 integration target sites in the human genome: comparison with those of other retroviruses. J Virol 2007, 81:6731-6741. 10.1128/JVI.02752-06, 1900082, 17409138.
41. Trobridge GD, Miller DG, Jacobs MA, Allen JM, Kiem HP, Kaul R, Russell DW. Foamy virus vector integration sites in normal human cells. Proc Natl Acad Sci U S A 2006, 103:1498-1503. 10.1073/pnas.0510046103, 1360565, 16428288.
42. Narezkina A, Taganov KD, Litwin S, Stoyanova R, Hayashi J, Seeger C, Skalka AM, Katz RA. Genome-wide analyses of avian sarcoma virus integration sites. J Virol 2004, 78:11656-11663. 10.1128/JVI.78.21.11656-11663.2004, 523270, 15479807.
43. Ciuffi A, Llano M, Poeschla E, Hoffmann C, Leipzig J, Shinn P, Ecker JR, Bushman F. A role for LEDGF/p75 in targeting HIV DNA integration. Nat Med 2005, 11:1287-1289. 10.1038/nm1329, 16311605.
44. Koppe B, Menendez-Arias L, Oroszlan S. Expression and purification of the mouse mammary tumor virus gag-pro transframe protein p30 and characterization of its dUTPase activity. J Virol 1994, 68:2313-2319. 236707, 8139016.
45. Payne SL, Elder JH. The role of retroviral dUTPases in replication and virulence. Curr Protein Pept Sci 2001, 2:381-388. 10.2174/1389203013381008, 12374097.
46. Yamashita M, Emerman M. The cell cycle independence of HIV infections is not determined by known karyophilic viral elements. PLoS Pathog 2005, 1:e18. 10.1371/journal.ppat.0010018, 1283251, 16292356.
47. Brass AL, Dykxhoorn DM, Benita Y, Yan N, Engelman A, Xavier RJ, Lieberman J, Elledge SJ. Identification of host proteins required for HIV infection through a functional genomic screen. Science 2008, 319:921-926. 10.1126/science.1152725, 18187620.
48. Beyer AR, Bann DV, Rice B, Pultz IS, Kane M, Goff SP, Golovkina TV, Parent LJ. Nucleolar trafficking of the mouse mammary tumor virus gag protein induced by interaction with ribosomal protein L9. J Virol 2013, 87:1069-1082. 10.1128/JVI.02463-12, 3554096, 23135726.
49. Darzynkiewicz Z, Juan G, Bedner E. Determining cell cycle stages by flow cytometry. Curr Protoc Cell Biol 2001, Chapter 8:Unit 8 4.
50. Indik S, Gunzburg WH, Kulich P, Salmons B, Rouault F. Rapid spread of mouse mammary tumor virus in cultured human breast cells. Retrovirology 2007, 4:73. 10.1186/1742-4690-4-73, 2169256, 17931409.
51. Kent WJ. BLAT-the BLAST-like alignment tool. Genome Res 2002, 12:656-664. 10.1101/gr.229202. Article published online before March 2002, 187518, 11932250.
52. Chan HH, Tsai SJ, Sun HS. http://www.binfo.ncku.edu.tw/TAG/GeneDoc.php.
53. Giardine B, Riemer C, Hardison RC, Burhans R, Elnitski L, Shah P, Zhang Y, Blankenberg D, Albert I, Taylor J, Miller W, Kent WJ, Nekrutenko A. Galaxy: a platform for interactive large-scale genome analysis. Genome Res 2005, 15:1451-1455. 10.1101/gr.4086505, 1240089, 16169926.